Provoked vulvodynia causing burning or stinging at the vaginal entrance. Treated with topical compounding, nerve blocks, pelvic PT coordination, and vestibulectomy when medically indicated.

Menopausal tissue thinning causing painful intercourse, dryness, and urinary symptoms. Treated with local hormonal therapy, MonaLisa Touch laser, and restorative protocols.

Ultra-potent topical corticosteroids, calcineurin inhibitors, and maintenance protocols — alongside monitoring for structural changes and malignant transformation risk.

Fractional laser therapy for early and late-stage tissue restoration; surgical correction for clitoral adhesions, phimosis, or structural scarring caused by advanced disease.

Testosterone optimization, bioidentical estrogen protocols, and DHEA supplementation — addressing the hormonal root causes of hypoactive sexual desire disorder (HSDD).

FDA-approved and off-label pharmacologic options including flibanserin and bremelanotide, combined with a comprehensive evaluation of contributing factors.

Customized compounded creams — both hormonal (e.g., testosterone, estrogen, DHEA) and non-hormonal (e.g., bupropion, arginine, botanical extracts) — may be formulated to target localized symptoms and enhance sexual desire. These topical applications can be tailored to individual needs and used alone or in conjunction with systemic therapies for a more comprehensive approach.

Injections that use the body’s own growth factors to stimulate tissue regeneration and enhance sensitivity.

Clitoral adhesion release and clitoropexy to restore anatomical access — particularly in patients with Lichen Sclerosis-related adhesions reducing clitoral exposure and sensitivity.

Surgical or minimally invasive procedures designed to improve muscle tone and support, potentially enhancing sexual function.

A fractional CO₂ laser therapy that promotes collagen production, improves vaginal tissue health, and may restore responsiveness.

Customized topical formulations, hormonal or non-hormonal, tailored to address individual needs and improve arousal and orgasmic response.

A complex, often misunderstood condition requiring careful multimodal assessment including neurologic, hormonal, and musculoskeletal evaluation before treatment planning.

Individualized treatment combining pharmacologic, procedural, and lifestyle approaches — coordinated with pelvic floor specialists and neurologists when needed.

Genitourinary Syndrome of Menopause (GSM) is caused by declining estrogen and can lead to vaginal dryness, irritation, urinary symptoms, and painful intercourse. These changes are common—but treatable. We offer advanced, personalized therapies to restore vaginal health, improve comfort, and help you feel like yourself again.

Vaginal laxity is the loss of vaginal tightness and support, often related to childbirth, aging, or hormonal changes. It can impact sensation, confidence, and sexual wellness. Our customized treatments—both non-surgical and surgical—are designed to restore tone, function, and intimacy.

Vaginismus is an involuntary tightening of the pelvic floor muscles that can make penetration painful or difficult. It’s more common than many realize and highly treatable. We provide a compassionate, step-by-step approach to relieve pain, restore function, and rebuild confidence in intimacy.